Top Markets
Coin of the day
BioSyntech, Inc. BioSyntech, Inc.

BioSyntech, Inc.

BSYI
Rank in Stocks #40152
BioSyntech, Inc. is dedicated to developing advanced biotherapeutic thermogels... BioSyntech, Inc. is dedicated to developing advanced biotherapeutic thermogels aimed at both repairing tissues and delivering therapeutic compounds. The company's key product pipeline features BST-CarGel, a biodegradable gel designed for cartilage repair; BST-InPod, intended for alleviating heel discomfort; BST-DermOn, for managing and healing chronic wounds; BST-Ossifil, used in bone void filling; BST-Ossifix, which provides structural support for bones; and BST-Disc, focused on restoring intervertebral discs. Beyond these, BioSyntech offers injectable products leveraging BST-Gel technology to precisely deliver biotherapeutics. Its technological assets also include Arthro-BST, an arthroscopic device for the non-destructive evaluation of cartilage degradation or repair, and Mach-1, a micromechanical testing system for assessing the properties of various tissues and materials. The company also manufactures ultra-pure chitosans under the Ultrasan brand and offers both manufacturing and analytical services. Founded in 1994 and based in Laval, Canada, BioSyntech Inc. initiated administration proceedings under the Bankruptcy and Insolvency Act on May 12, 2010, and is currently undergoing reorganization.
Share Price
$0.00001
Last synced: 2025-09-24
Market Cap
$229.03K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CA
Trade BioSyntech, Inc. (BSYI)

Category

Stock split history for BioSyntech, Inc. (BSYI)
BioSyntech, Inc. stock (symbol: BSYI) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 14, 2026.
One BSYI share bought prior to Aug 14, 2026 would equal to 0 BSYI shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE